157 related articles for article (PubMed ID: 8058317)
1. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
Gruda MC; Kovary K; Metz R; Bravo R
Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter.
Gille H; Sharrocks AD; Shaw PE
Nature; 1992 Jul; 358(6385):414-7. PubMed ID: 1322499
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
4. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
5. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
Baptist M; Dumont JE; Roger PP
Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
[TBL] [Abstract][Full Text] [Related]
8. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
Lallemand D; Spyrou G; Yaniv M; Pfarr CM
Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
[TBL] [Abstract][Full Text] [Related]
9. MAP kinase-independent induction of proto-oncogene c-fos mRNA by hemin in human cells.
Masuya Y; Kameshita I; Fujisawa H; Kohno H; Hioki K; Tokunaga R; Taketani S
Biochem Biophys Res Commun; 1999 Jun; 260(1):289-95. PubMed ID: 10381381
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in vivo.
Birnbaum MJ; van Zundert B; Vaughan PS; Whitmarsh AJ; van Wijnen AJ; Davis RJ; Stein GS; Stein JL
J Cell Biochem; 1997 Aug; 66(2):175-83. PubMed ID: 9213219
[TBL] [Abstract][Full Text] [Related]
11. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK.
Murakami M; Ui M; Iba H
Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014
[TBL] [Abstract][Full Text] [Related]
12. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
Hurd TW; Culbert AA; Webster KJ; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of transcription factors and control of the cell cycle.
Boulikas T
Crit Rev Eukaryot Gene Expr; 1995; 5(1):1-77. PubMed ID: 7549180
[TBL] [Abstract][Full Text] [Related]
14. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines.
Rezzonico R; Loubat A; Lallemand D; Pfarr CM; Far DF; Proudfoot A; Rossi B; Ponzio G
Oncogene; 1995 Sep; 11(6):1069-78. PubMed ID: 7566966
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression.
Manak JR; Prywes R
Oncogene; 1993 Mar; 8(3):703-11. PubMed ID: 8437853
[TBL] [Abstract][Full Text] [Related]
17. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
[TBL] [Abstract][Full Text] [Related]
18. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites.
Wang Y; Prywes R
Oncogene; 2000 Mar; 19(11):1379-85. PubMed ID: 10723128
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
20. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
